Company	Market Cap (₹in Cr.)	P/E (x)	P/B(x)	EV / EBITDA(x)	Dividend Yield(%)	EPS
Glaxosmithkline Pharmaceu..	42,616.63	40.26	17.26	1445.4	2.27	62.48
Sun Pharmaceutical Indust..	422,990.76	132.85	18.85	6053.68	0.91	13.27
Divis Laboratories Ltd	256,309.91	85.56	9.43	3921	0.31	112.85
Torrent Pharmaceuticals L..	173,603.69	89.09	16.9	4001.11	0.74	51.23
Laurus Labs Ltd	121,300.09	139.01	10.19	1515.69	0.09	16.15

More >

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of ₹ Returns(%)

in Months Ago

My investment would be worth₹ with a Loss of

Share Holding

CATEGORY	NO. OF SHARES	PERCENTAGE (%)
Total Foreign	8927642	5.27
Total Institutions	14365965	8.48
Total Govt Holding	94	0.00
Total Non Promoter Corporate Holding	1194089	0.71
Total Promoters	127054524	75.00
Total Public & others	17863720	10.54
Total	169406034	100

Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others

Research Reports

DATE	TITLE
11-Oct-2019 10:18 PM	Indian Oil Corporation (1QFY20): Petchem to shine out. Maintain BUY
11-Oct-2019 10:18 PM	Materials (Oil & Gas, Chemicals): 1QFY20E Results Preview
11-Oct-2019 10:18 PM	Sector Technical Report - Nifty PSE Index - 070919
11-Oct-2019 10:18 PM	Sector Technical Report - Nifty Metal Index

More >

Corporate Actions

More >

About Company

GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as 'Glindia Limited' in November, 1924. The Company' s name was changed to Glaxo (India) Limited' in 1987 and was again changed to 'GlaxoSmithKline Pharmaceuticals Limited' dated October 22, 2001.

GlaxoSmithKline Pharmaceuticals Limited is the Indian subsidiary of GSK plc, a UK-based, science-led global healthcare organisation focused on uniting science, technology and talent to get ahead of disease. The Company is headquartered in Mumbai and it has six branch offices, one manufacturing facility at Nashik in Maharashtra, 20 contract manufacturing organisations (CMOs) with regional and sales hubs across India. The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals.

The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease. Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases. They also offer a range of vaccines, for the prevention of Hepatitis A, Hepatitis B, Invasive Disease caused by H, Influenza, Chickenpox, Diphtheria, Pertussis, Tetanus, Rotavirus, Cervical Ca...

More >